Engineering APOBEC3A deaminase for highly accurate and efficient base editing

Lei Yang,Yanan Huo,Man Wang,Dan Zhang,Tianai Zhang,Hao Wu,Xichen Rao,Haowei Meng,Shuming Yin,Jiale Mei,Dexin Zhang,Xi Chen,Jia Lv,Meizhen Liu,Yiyun Cheng,Yuting Guan,Bo Feng,Gaojie Song,Chengqi Yi,Mingyao Liu,Fanyi Zeng,Liren Wang,Dali Li
DOI: https://doi.org/10.1038/s41589-024-01595-4
Abstract:Cytosine base editors (CBEs) are effective tools for introducing C-to-T base conversions, but their clinical applications are limited by off-target and bystander effects. Through structure-guided engineering of human APOBEC3A (A3A) deaminase, we developed highly accurate A3A-CBE (haA3A-CBE) variants that efficiently generate C-to-T conversion with a narrow editing window and near-background level of DNA and RNA off-target activity, irrespective of methylation status and sequence context. The engineered deaminase domains are compatible with PAM-relaxed SpCas9-NG variant, enabling accurate correction of pathogenic mutations in homopolymeric cytosine sites through flexible positioning of the single-guide RNAs. Dual adeno-associated virus delivery of one haA3A-CBE variant to a mouse model of tyrosinemia induced up to 58.1% editing in liver tissues with minimal bystander editing, which was further reduced through single dose of lipid nanoparticle-based messenger RNA delivery of haA3A-CBEs. These results highlight the tremendous promise of haA3A-CBEs for precise genome editing to treat human diseases.
What problem does this paper attempt to address?